Clinical Trials Logo

Dementia With Lewy Bodies (DLB) clinical trials

View clinical trials related to Dementia With Lewy Bodies (DLB).

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT03030586 Recruiting - Clinical trials for Frontotemporal Lobar Degeneration

ADDIA Proof-of-Performance Clinical Study

ADDIA
Start date: September 1, 2016
Phase:
Study type: Observational

The objective of the ADDIA clinical Proof-of-Performance study is to validate the performance of ADDIA' blood biomarkers for diagnosis of Alzheimer's disease (AD). ADDIA clinical study is a multi-centre, non-interventional, prospective, proof-of-performance study with only one visit. About 800 well-characterized subjects will be recruited into 3 groups in 2:1:1 ratio, namely patients with Alzheimer's disease (AD), patients with non-AD neurodegenerative disease (NAD) and 200 control subjects (healthy as compared to their age). - 400 patients with Alzheimer's disease (AD): 200 patients with mild AD, 200 patients with moderate-to-severe AD, - 200 patients with non-Alzheimer's neurodegenerative diseases (NAD), - 200 controls (healthy as compared to their age).